<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14734</article-id><article-id pub-id-type="doi">10.7554/eLife.14734</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title><italic>TP53</italic> drives invasion through expression of its Δ133p53β variant</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-51793"><name><surname>Gadea</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51794"><name><surname>Arsic</surname><given-names>Nikola</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51795"><name><surname>Fernandes</surname><given-names>Kenneth</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51796"><name><surname>Diot</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51797"><name><surname>Joruiz</surname><given-names>Sébastien M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51798"><name><surname>Abdallah</surname><given-names>Samer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52539"><name><surname>Meuray</surname><given-names>Valerie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52530"><name><surname>Vinot</surname><given-names>Stéphanie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51801"><name><surname>Anguille</surname><given-names>Christelle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51802"><name><surname>Remenyi</surname><given-names>Judit</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51803"><name><surname>Khoury</surname><given-names>Marie P</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51804"><name><surname>Quinlan</surname><given-names>Philip R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52532"><name><surname>Purdie</surname><given-names>Colin A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52538"><name><surname>Jordan</surname><given-names>Lee B</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51807"><name><surname>Fuller-Pace</surname><given-names>Frances V</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5859-2932</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51808"><name><surname>de Toledo</surname><given-names>Marion</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51809"><name><surname>Cren</surname><given-names>Maïlys</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51810"><name><surname>Thompson</surname><given-names>Alastair M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-43931"><name><surname>Bourdon</surname><given-names>Jean-Christophe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-46360"><name><surname>Roux</surname><given-names>Pierre</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0671-5413</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>CNRS, Centre de Recherche de Biochimie Macromoléculaire de Montpellier</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">Division of Cancer Research</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution>Université Montpellier</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1082"><name><surname>Espinosa</surname><given-names>Joaquín M</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>j.bourdon@dundee.ac.uk</email> (JB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>pierre.roux@crbm.cnrs.fr</email> (PR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>09</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e14734</elocation-id><history><date date-type="received"><day>29</day><month>01</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Gadea et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Gadea et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-14734-v1.pdf"/><abstract><p><italic>TP53</italic> is conventionally thought to prevent cancer formation and progression to metastasis, while mutant <italic>TP53</italic> has transforming activities. However, in the clinic, <italic>TP53</italic> mutation status does not accurately predict cancer progression. Here we report, based on clinical analysis corroborated with experimental data, that the p53 isoform Δ133p53β promotes cancer cell invasion, regardless of <italic>TP53</italic> mutation status. Δ133p53β increases risk of cancer recurrence and death in breast cancer patients. Furthermore Δ133p53β is critical to define invasiveness in a panel of breast and colon cell lines, expressing WT or mutant <italic>TP53</italic>. Endogenous mutant Δ133p53β depletion prevents invasiveness without affecting mutant full-length p53 protein expression. Mechanistically WT and mutant Δ133p53β induces EMT. Our findings provide explanations to 2 long-lasting and important clinical conundrums: how WT <italic>TP53</italic> can promote cancer cell invasion and reciprocally why mutant <italic>TP53</italic> gene does not systematically induce cancer progression.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000301</institution-id><institution>Breast Cancer Campaign</institution></institution-wrap></funding-source><award-id>2012MaySF127</award-id><principal-award-recipient><name><surname>Bourdon</surname><given-names>Jean-Christophe</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Samples were examined following Local Research EthicsCommittee approval under delegated authority by the Tayside Tissue Bank(www.taysidetissuebank.org).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-14734-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>